Cerebrospinal fluid lymphocytosis: A hallmark of neurological immune related adverse events (irAEs) during checkpoint inhibitor treatment
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2018-10, Vol.29, p.viii426-viii426 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | viii426 |
|---|---|
| container_issue | |
| container_start_page | viii426 |
| container_title | Annals of oncology |
| container_volume | 29 |
| creator | Suijkerbuijk, K.P. De Vos, F.Y.F.L. Koldenhof, J.J. Snijders, T.J. |
| description | |
| doi_str_mv | 10.1093/annonc/mdy288.070 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdy288_070</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419496543</els_id><sourcerecordid>S0923753419496543</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2300-de44dcc22928c63d3d5729d9a3f6a98d4f3a15dd0e921a3c2f1f07af925e18fa3</originalsourceid><addsrcrecordid>eNp9kLtOwzAUhi0EoqXwACzIIwwpvuRmmKqqXCQkFpgj1z5uTRM7spNKfQTemqAAI9NZvv_X-T-ELimZUyL4rXTOO3Xb6AMryzkpyBGa0iwXSUlSeoymRDCeFBlPJ-gsxg9CSC6YOEUTzigvSJFP0ecSAqyDj611ssam7q3G9aFpt14dOh9tvMMLvJV13ciww95gB33wtd9YNfC2aXoHOEAtO9BY6j2ECBj24LqIr21YrOIN1n2wboPVFtSu9dZ12LqtXdvOB9wFkF0z4OfoxMg6wsXPnaH3h9Xb8il5eX18Xi5eEsU4IYmGNNVKMSZYqXKuuc4KJrSQ3ORSlDo1XNJMawKCUckVM9SQQhrBMqClkXyG6NirhtUxgKnaYIdxh4qS6ltrNWqtRq3VoHXIXI2Ztl83oP8Svx4H4H4EYPh8byFUUVlwCrQNoLpKe_tP_ReJLY8K</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Cerebrospinal fluid lymphocytosis: A hallmark of neurological immune related adverse events (irAEs) during checkpoint inhibitor treatment</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Suijkerbuijk, K.P. ; De Vos, F.Y.F.L. ; Koldenhof, J.J. ; Snijders, T.J.</creator><creatorcontrib>Suijkerbuijk, K.P. ; De Vos, F.Y.F.L. ; Koldenhof, J.J. ; Snijders, T.J.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy288.070</identifier><identifier>PMID: 32137076</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Annals of oncology, 2018-10, Vol.29, p.viii426-viii426</ispartof><rights>2018 THE AUTHORS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32137076$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Suijkerbuijk, K.P.</creatorcontrib><creatorcontrib>De Vos, F.Y.F.L.</creatorcontrib><creatorcontrib>Koldenhof, J.J.</creatorcontrib><creatorcontrib>Snijders, T.J.</creatorcontrib><title>Cerebrospinal fluid lymphocytosis: A hallmark of neurological immune related adverse events (irAEs) during checkpoint inhibitor treatment</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kLtOwzAUhi0EoqXwACzIIwwpvuRmmKqqXCQkFpgj1z5uTRM7spNKfQTemqAAI9NZvv_X-T-ELimZUyL4rXTOO3Xb6AMryzkpyBGa0iwXSUlSeoymRDCeFBlPJ-gsxg9CSC6YOEUTzigvSJFP0ecSAqyDj611ssam7q3G9aFpt14dOh9tvMMLvJV13ciww95gB33wtd9YNfC2aXoHOEAtO9BY6j2ECBj24LqIr21YrOIN1n2wboPVFtSu9dZ12LqtXdvOB9wFkF0z4OfoxMg6wsXPnaH3h9Xb8il5eX18Xi5eEsU4IYmGNNVKMSZYqXKuuc4KJrSQ3ORSlDo1XNJMawKCUckVM9SQQhrBMqClkXyG6NirhtUxgKnaYIdxh4qS6ltrNWqtRq3VoHXIXI2Ztl83oP8Svx4H4H4EYPh8byFUUVlwCrQNoLpKe_tP_ReJLY8K</recordid><startdate>201810</startdate><enddate>201810</enddate><creator>Suijkerbuijk, K.P.</creator><creator>De Vos, F.Y.F.L.</creator><creator>Koldenhof, J.J.</creator><creator>Snijders, T.J.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201810</creationdate><title>Cerebrospinal fluid lymphocytosis: A hallmark of neurological immune related adverse events (irAEs) during checkpoint inhibitor treatment</title><author>Suijkerbuijk, K.P. ; De Vos, F.Y.F.L. ; Koldenhof, J.J. ; Snijders, T.J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2300-de44dcc22928c63d3d5729d9a3f6a98d4f3a15dd0e921a3c2f1f07af925e18fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Suijkerbuijk, K.P.</creatorcontrib><creatorcontrib>De Vos, F.Y.F.L.</creatorcontrib><creatorcontrib>Koldenhof, J.J.</creatorcontrib><creatorcontrib>Snijders, T.J.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Suijkerbuijk, K.P.</au><au>De Vos, F.Y.F.L.</au><au>Koldenhof, J.J.</au><au>Snijders, T.J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cerebrospinal fluid lymphocytosis: A hallmark of neurological immune related adverse events (irAEs) during checkpoint inhibitor treatment</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2018-10</date><risdate>2018</risdate><volume>29</volume><spage>viii426</spage><epage>viii426</epage><pages>viii426-viii426</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>32137076</pmid><doi>10.1093/annonc/mdy288.070</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2018-10, Vol.29, p.viii426-viii426 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdy288_070 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| title | Cerebrospinal fluid lymphocytosis: A hallmark of neurological immune related adverse events (irAEs) during checkpoint inhibitor treatment |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T12%3A46%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cerebrospinal%20fluid%20lymphocytosis:%20A%20hallmark%20of%20neurological%20immune%20related%20adverse%20events%20(irAEs)%20during%20checkpoint%20inhibitor%20treatment&rft.jtitle=Annals%20of%20oncology&rft.au=Suijkerbuijk,%20K.P.&rft.date=2018-10&rft.volume=29&rft.spage=viii426&rft.epage=viii426&rft.pages=viii426-viii426&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy288.070&rft_dat=%3Celsevier_cross%3ES0923753419496543%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32137076&rft_els_id=S0923753419496543&rfr_iscdi=true |